Treatment with low-dose diazoxide in two growth-retarded prepubertal girls with glycogen storage disease type Ia resulted in catch-up growth

Journal of Inherited Metabolic Disease

Volumn 20, Issue 6, 1997, Pages 790-798

  Nuoffer, J M ^a   Mullis, P E ^a   Wiesmann, U N ^a,b  

^a UNIVERSITY CHILDREN S HOSPITAL   (Switzerland)

^b UNIVERSITY OF BERN   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ALLOPURINOL; CHOLESTEROL; DIAZOXIDE; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LACTIC ACID; TRIACYLGLYCEROL;

ADOLESCENT; ARTICLE; BODY HEIGHT; BONE AGE; CASE REPORT; CATCH UP GROWTH; CHILD; CHOLESTEROL BLOOD LEVEL; DRUG EFFICACY; DRUG SAFETY; FEMALE; GLUCOSE BLOOD LEVEL; GLYCOGEN STORAGE DISEASE TYPE 1; GROWTH RETARDATION; HUMAN; LACTATE BLOOD LEVEL; LACTIC ACIDOSIS; PREPUBERTY; TRIACYLGLYCEROL BLOOD LEVEL;

ACIDOSIS, LACTIC; BLOOD GLUCOSE; CHILD; CHILD, PRESCHOOL; DIAZOXIDE; FEMALE; FOOD; GLYCOGEN STORAGE DISEASE TYPE I; GROWTH; GROWTH DISORDERS; HUMANS;

EID: 0030727964     PISSN: 01418955     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1005319818015     Document Type: Article

References (15)

1. Bartolozzi G, Bernini G, Marianelli L, Nasi P (1975) Two cases of type-1 glycogenosis with hyperuricemia. Minerva Pediatr 27: 1229-1241.
2. Challa A, Krieg RJ Jr, Thabet MA, Veldhuis JD, Chan JD (1993) Metabolic acidosis inhibits growth hormone secretion in rats: mechanism of growth retardation. Am J Physiol 265 (4 Pt 1): E547-553.
3. Chen YT, Bazzarre CH, Lee MM, Sidbury JB, Coleman RA (1993) Type I glycogen storage disease: nine years of management with cornstarch. Eur J Pediatr 152 (supplement 1): S56-S59.
4. + channels in an insulin-secreting cell line. J Membr Biol 99: 215-224.
5. + channel openers. Trends Pharmacol Sci 11: 417-422.
6. Fernandes, J, Berger R (1987) Urinary excretion of lactate, 2-oxoglutarate, citrate, and glycerol in patient with glycogenosis type I. Pediatr Res 21: 279-282.
7. Gardoni L, Giranzani F (1978) Treatment of a case of type-1 glycogenosis with diazoxide. Minerva Pediatr 30: 1535-1542.
8. Goodman HG, Morishima A, Grumbach MM (1968) The use of diazoxide in hypoglycemia in childhood. Ann NY Acad Sci 152(2): 367-372.
9. Greulich WW, Pyle SI (1959) Radiological Atlas of Skeletal Development of the Hand and Wrist. Stanford CA: Stanford University Press.
10. Mehls O, Blum WF, Schaefer F, Tonshoff B, Scharer K (1992) Growth failure in renal disease. Baillière's Clin Endocrinol Metab 6: 665-685.
11. Prader A, Largo RH, Molinari L, Issler C (1989) Physical growth of Swiss children from birth to 20 years of age. First Zurich longitudinal study of growth and development. Helv Paediatr Acta Suppl 52: 1-125.
12. Rennert OM, Mukhopadhyay D (1968) Diazoxide in Von Gierke's disease. Arch Dis Child 43: 358-361.
13. Smit GPA (1993) The long-term outcome of patients with glycogen storage disease type Ia. Eur J Pediatr 152 (supplement 1): S52-S55.
14. Ventura A, Canciani M, Tamaro P (1983) Efficacy of diazoxide in preventing hypoglycemia in a child affected by hypopituitary dwarfism. Acta Paediatr Scand 72: 309-311.
15. Wolfsdorf JI, Rudlin CR, Crigler JF Jr (1990) Physical growth and development of children with type 1 glycogen-storage disease: comparison of the effects of long-term use of dextrose and uncooked cornstarch. Am J Clin Nutr 52: 1051-1057.